Abstract
BackgroundLycopene (lyc) supplementation was shown to efficiently prevent multiple hepatic injuries. This study was assembled to examine lyc protective effects against non-alcoholic fatty liver disease (NAFLD) experimentally-induced in rats. MethodsThe experiment was completed in eight weeks. Rats were indiscriminately distributed into four main groups: the control group and the high fat diet (HFD) fed group, received 1 mL/kg corn oil orally 3 times per week. Lyc only-treated group and HFD/lyc fed group, received 4 mg/kg of lyc orally 3 times per week. ResultsLyc significantly renovated liver enzymes and alleviated histopathological abrasions induced by HFD. Moreover, lyc significantly enhanced insulin receptor substrate 2 (IRS 2) expression by 25 % and ameliorated oxidative stress injury through restoring GSH level by 218 % and Nrf 2 expression by 56 %. Additionally, lyc significantly reduced pro-inflammatory cytokines production; interleukin-6; IL-6 and tumor necrosis factor-alpha; TNF-α by 52 % and 57 % respectively, and inhibited nuclear factor-κB (NF-κB) by 52 %. Finally, lyc significantly reduced transforming growth factor-β (TGF-β) expression by 52 % and α-smooth muscle actin (α-SMA) expression by 53 % as well as collagen accumulation. ConclusionAccording to these findings, lyc may be recommended as a promising dietary agent in the management of NAFLD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
